Farmacon Global

BLOG

Get valuable insights and information from our team of experts to propel your clinical trials and market access projects forward. Explore a wealth of knowledge crafted to accelerate enrollment with diversity, providing you with the strategies and tips needed for success in the dynamic landscape of clinical research.
farmacon-global-logo

Quick Links

Contact

© 2024 All Rights Reserved

Sara Tylosky, MBA
CEO

Sara Tylosky, MBA, CEO at Farmacon Global, brings over 20 years of experience leading teams in both large and small pharmaceutical and biotech environments. She has led Farmacon Global, a strategic CRO of medical consultants, in accelerating clinical trials, increasing diversity, supporting enrollment, and paving the way to market access in emerging markets.

Known for her high cultural intelligence and problem-solving skills, Sara and her team specialize in Rare Diseases, Immunology, Infectious Diseases, Cancer, and Vaccines. Fluent in Spanish and having lived on four continents, she has a special focus on Latin America while actively expanding into other key markets globally. Sara’s direction plays a pivotal role in steering Farmacon Global toward healthcare innovation and global market leadership.